End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 DKK | -8.82% | -9.45% | -48.73% |
04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
04-12 | Curasight A/S Announces Board Changes | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- CURAS Stock
- News Curasight A/S
- Official Publications